Vital Strategies and the National Council for Behavioral Health have developed a toolkit to help jails and prisons implement and expand access to medications for opioid use disorder, such as methadone and buprenorphine, for incarcerated people struggling with opioid dependence.
To reduce vulnerability to opioid overdose and provide quality care for incarcerated individuals with opioid use disorder, the National Council, in partnership with Vital Strategies and faculty from Johns Hopkins University, developed a new resource guide titled: Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit with funding support from CDC Foundation and Bloomberg Philanthropies.
People who have been incarcerated are up to 100 times more likely than the general public to die from overdose in the weeks following release from incarceration. Despite high rates of opioid dependence among justice-involved individuals, very few jails and prisons offer access to these medications, which can protect against the risk of death.
Expanding access to methadone and buprenorphine across settings, including jails and prisons, is a top priority for Vital Strategies’ overdose prevention work. We look forward to partnering with state and local governments to ensure these lifesaving medications get to the people who need them.
A Comprehensive Approach to Improving Emergency Obstetric and Newborn Care in Kigoma, Tanzania
Improving Maternal and Reproductive Health in Kigoma, Tanzania: A 13-Year Initiative
Covitel – Inquérito Telefônico de Fatores de Risco para Doenças Crônicas não Transmissíveis…
Promoting Healthy Environments for Children By Using Indicators
Validation of physician certified verbal autopsy using conventional autopsy: a large study of…
Inspirer une mobilité urbaine qui sauve des vies en améliorant la qualité de…
Urgence d’agir et occasions manquées
Mass Media for Tobacco Control Advocacy in Senegal
Testing Communication Concepts on COVID-19 Contact Tracing Among Black and Latinx/Hispanic People in…
QT prolongation in the STREAM Stage 1 Trial